Active · per the CBE, 17 November 2026

GERARDIPHAR

BE0867474364

Rechtspersoon Private limited company 2 establishments

GERARDIPHAR is a pharmacy in Brugge. Private Limited, started on 28 September 2004, 2 establishments.

Stationslaan 42, 8200 Brugge

Behind the company: VEERLE CALLEBAUT.

Active for

22 year, 1 month

Financials

Financial year 2024

GERARDIPHAR from Brugge, company number BE0867474364, closed financial year 2024 with a result of € 162,129 after tax. For that financial year GERARDIPHAR recorded a gross margin of € 615,711 and equity of € 329,264. Compared with financial year 2023, the result moved from € 87,534 to € 162,129. Profitable, and profit is growing. The buffer shrank hard: equity is 64 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 25, 2025.

What it is worth Shrank hard

€ 329,264

▼ 64% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 162,129

▲ 85% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 436,303

▲ 31% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 325,849.

People and assets in 2024

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 223,244

▼ 22% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 79,323

▼ 81% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go

€ 470,977

▼ 28% vs 2023

€ 91,489 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 1,905

▼ 99% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 75,559

▼ 41% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2021202220232024Change 2023 → 2024
Gross margin € 463,296 € 656,178 € 664,015 € 615,711 ▼ 7%
Profit after taxes € 84,746 € 170,736 € 87,534 € 162,129 ▲ 85%
Equity € 796,255 € 759,565 € 910,249 € 329,264 ▼ 64%
Total debts € 1,311,315 € 1,326,712 € 1,239,388 € 838,789 ▼ 32%
Cash € 174,033 € 179,532 € 334,309 € 436,303 ▲ 31%
Land & buildings € 777,697 € 728,799 € 671,604 € 616,421 ▼ 8%
Retained profit € 777,655 € 740,965 € 891,649 € 325,849 ▼ 63%
Dividend € 0 € 207,426 € 0 € 0
Bank debt € 925,867 € 762,448 € 651,104 € 470,977 ▼ 28%
Balance sheet total € 2,107,570 € 2,086,277 € 2,149,637 € 1,168,053 ▼ 46%
Employees (FTE) 4.7 6.1 0 0

By gross margin, GERARDIPHAR ranks 1st of 16 companies with main activity “Detailhandel in farmaceutische producten” in Brugge that publish figures (fiscal year 2024).

Key figures of GERARDIPHAR, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to GERARDIPHAR?

What happened at GERARDIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: profit of € 162,129 (▲ 85% vs 2023). filed late Source: NBB ↗
  • VEERLE CALLEBAUT became a director. NBB
  • Start of the company according to the CBE. KBO
  • New establishment in Brugge. KBO
  • New establishment in Geraardsbergen. KBO

In short

From € 84,746 profit in 2021 to € 162,129 profit in 2024.

Paid € 201,299 in corporate taxes since 2021.

Best year ever: 2022, with € 170,736 profit.

On average € 107,600 of value added per employee in 2022.

Management

VEERLE CALLEBAUT
GERARDIPHAR

Behind GERARDIPHAR is VEERLE CALLEBAUT.

Directors

According to the 2024 annual accounts

VEERLE CALLEBAUT

Manager

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Stationslaan 42

8200 Brugge

2.139.609.766

Marktweg(Goe) 106

9500 Geraardsbergen

Active since 23 September 2004

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Brugge

Same main activity (Detailhandel in farmaceutische producten), 18 active companies in Brugge, largest first.

BRAFO

€ 601,919 gross margin · 2025

APOTHEEK CANNAERT

€ 599,992 gross margin · 2025

BRAECKEVELT-LAFAUT

€ 584,272 gross margin · 2025

Gobert Sophie

€ 565,505 gross margin · 2025

APOTHEEK MANITOBA

€ 438,737 gross margin · 2025

APOTHEEK DE PAUW - ST-ANDRIES

€ 294,345 gross margin · 2025

Details

Company number
0867.474.364
VAT number
BE 0867.474.364
Registered office
Stationslaan 42, 8200 Brugge
Names & denominations
GERARDIPHAR
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
28 September 2004
Peppol
Active · Active since 28 Aug 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

Frequently asked questions

What does GERARDIPHAR do?
GERARDIPHAR is a pharmacy in Brugge. Private Limited, started on 28 September 2004, 2 establishments.
What is the address of GERARDIPHAR?
The registered office of GERARDIPHAR is located at Stationslaan 42, 8200 Brugge.
Is GERARDIPHAR still active?
Yes. According to the CBE (17 November 2026) GERARDIPHAR is active, legal situation “Normale toestand”, started on 28 September 2004.
Is GERARDIPHAR registered on Peppol?
Yes, GERARDIPHAR is registered on the Peppol network with ID 0208:0867474364.
What is the enterprise number of GERARDIPHAR?
The enterprise number of GERARDIPHAR is BE0867474364.
When was GERARDIPHAR founded?
GERARDIPHAR was founded on 28 September 2004.